---
title: "Brooks Laboratories Ltd (BROOKS) — Share Price, Financials & Analysis"
symbol: "BROOKS"
company: "Brooks Laboratories Ltd"
canonical: "https://tapetide.com/stocks/BROOKS"
isin: "INE650L01011"
nse_symbol: "BROOKS"
bse_code: "533543"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 186.17
generated_at: "2026-09-13T18:48:15.701Z"
---

# Brooks Laboratories Ltd (BROOKS)

Canonical page: https://tapetide.com/stocks/BROOKS

## Company

- **NSE Symbol:** BROOKS
- **BSE Code:** 533543
- **ISIN:** INE650L01011
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2011-09-05
- **CEO:** Mr. Prashant Rathi
- **Employees:** 323
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** brookslabs.net

## About

Incorporated in 2002, Brooks Laboratories Ltd is a pharmaceutical company working on contract basis catering to the critical care segment[1]

## Latest Price

- **Price:** ₹65.69
- **Change:** +1.84 (+2.88%)
- **Open:** ₹64.7
- **Day High:** ₹69.72
- **Day Low:** ₹63.12
- **Previous Close:** ₹63.85
- **Volume:** 101530
- **As Of:** 2026-09-11T09:59:23+00:00

## Key Fundamentals

Observed at 2026-09-11T04:39:02.460739Z.

- **Market Cap:** ₹186.17 Cr
- **Classification:** Microcap
- **P/E (reported):** 14.2
- **P/E (TTM):** 14.63
- **EPS (TTM):** ₹4.49
- **Book Value:** ₹41.64
- **Price to Book:** 1.53
- **Dividend Yield:** 0%
- **ROE:** 20.04%
- **ROCE:** 20.12%
- **Debt to Equity:** 0.07
- **Revenue (yearly):** ₹86.9 Cr
- **Net Income:** ₹24.6 Cr
- **EBITDA:** ₹8.2 Cr
- **52-Week High:** ₹163.9
- **52-Week Low:** ₹36.3
- **RSI (14):** 49.56

## Tapetide Score

- **Score:** 46 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Flat
- **Percentile:** 31.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 80.47 | 9% |
| growth | 26.66 | 9% |
| momentum | 57.92 | 12% |
| ownership | 46.42 | 24% |
| quality | 42.67 | 22% |
| valuation | 62.65 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 26.6% CAGR over last 5 years

### Weaknesses

- The company has delivered a poor sales growth of 2.11% over past five years.
- Company has a low return on equity of -2.02% over last 3 years.
- Contingent liabilities of Rs.123 Cr.
- Earnings include an other income of Rs.13.0 Cr.
- Promoter holding has decreased over last 3 years: -13.8%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 253.23% | 194.8% | 124.81% |
| ebitda margin growth | -160% | 35.67% | 82.47% | -164.77% |
| net income growth | -220% | -346% | 47% | 27% |
| revenue growth | 6.94% | 4.2% | 11% | 2% |
| roce | -198.14% | -331.53% | -172.43% | -15.55% |
| roe | -217.76% | -297.24% | -6.66% | -239.36% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 24.32 | 21.75 | 17.72 | 17.93 | 20.79 | 20.52 | 23.32 | 25.51 | 23.45 | 16.57 | 20.21 | 22.96 |
| Expenses | 25.42 | 25.12 | 27.25 | 19.85 | 24.2 | 22.02 | 24.58 | 22.38 | 20.93 | 15.84 | 19.53 | 24.3 |
| Operating Profit | -1.1 | -3.37 | -9.53 | -1.92 | -3.41 | -1.5 | -1.26 | 3.13 | 2.52 | 0.73 | 0.68 | -1.34 |
| OPM % | -4.52 | -15.49 | -53.78 | -10.71 | -16.4 | -7.31 | -5.4 | 12.27 | 10.75 | 4.41 | 3.36 | -5.84 |
| Other Income | 0.09 | 0.16 | 0.65 | 0.07 | 0.2 | 0.03 | 0.62 | 7.15 | 6.13 | 5.32 | 1.35 | 0.18 |
| Interest | 0.19 | 0.21 | 0.27 | 0.16 | 0.32 | 0.28 | 0.26 | 0.3 | 0.28 | 0.16 | 0.09 | 0.21 |
| Depreciation | 0.44 | 0.43 | 0.46 | 0.4 | 0.43 | 0.38 | 0.39 | 0.39 | 0.39 | 0.39 | 0.41 | 0.42 |
| Profit before tax | -1.64 | -3.85 | -9.61 | -2.41 | -3.96 | -2.13 | -1.29 | 9.59 | 7.98 | 5.5 | 1.53 | -1.79 |
| Tax % | 0 | 0.78 | 0 | 0 | 0 | 0 | 13.95 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1.64 | -3.88 | -9.61 | -2.41 | -3.96 | -2.13 | -1.46 | 9.58 | 7.98 | 5.5 | 1.52 | -1.79 |
| EPS in Rs | -0.62 | -1.48 | -3.66 | -0.92 | -1.51 | -0.81 | -0.5 | 3.25 | 2.71 | 1.87 | 0.52 | -0.61 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 77 | 91 | 63 | 79 | 83 | 86 | 83 |
| Expenses | 77 | 105 | 93 | 97 | 91 | 79 | 81 |
| Operating Profit | 1 | -14 | -30 | -18 | -8 | 7 | 3 |
| OPM % | 0.7 | -16 | -47 | -22 | -10 | 8 | 3.1 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 20 | 13 |
| Interest | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 2 | 2 | 2 | 2 |
| Profit before tax | -9 | -24 | -38 | -20 | -10 | 25 | 13 |
| Tax % | 115 | -19 | -19 | 0 | 2 | 0 | — |
| Net Profit | -19 | -19 | -31 | -20 | -10 | 25 | 13 |
| EPS in Rs | -7.4 | -4.31 | -7.97 | -7.46 | -3.38 | 8.34 | 4.49 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 25 | 25 | 25 | 26 | 29 | 29 |
| Reserves | 54 | 63 | 49 | 39 | 69 | 93 |
| Borrowings | 31 | 25 | 7 | 6 | 8 | 9 |
| Other Liabilities | 52 | 83 | 29 | 19 | 18 | 17 |
| Total Liabilities | 162 | 196 | 110 | 90 | 124 | 148 |
| Fixed Assets | 108 | 110 | 15 | 14 | 14 | 15 |
| CWIP | 1 | 15 | 0 | 0 | 0 | 1 |
| Investments | 0 | 0 | 64 | 43 | 74 | 92 |
| Other Assets | 54 | 71 | 31 | 34 | 36 | 40 |
| Total Assets | 162 | 196 | 110 | 90 | 124 | 148 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4 | -37 | -14 | -10 | 3 | 9 |
| Cash from Investing Activity | -5 | -25 | 0 | 0 | -45 | -3 |
| Cash from Financing Activity | 1 | 64 | 11 | 10 | 42 | 0 |
| Net Cash Flow | 0 | 2 | -3 | 0 | 0 | 7 |
| Free Cash Flow | -1 | -62 | -15 | -10 | 2 | 6 |
| CFO/OP | 1519 | 261 | 48 | 56 | -26 | 131 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 65 | 71 | 74 | 75 | 88 | 69 |
| Inventory Days | 178 | 157 | 80 | 60 | 61 | 77 |
| Days Payable | 233 | 159 | 165 | 97 | 90 | 80 |
| Cash Conversion Cycle | 9 | 68 | -12 | 38 | 59 | 66 |
| Working Capital Days | -85 | 34 | -37 | 34 | 43 | 34 |
| ROCE % | — | -16 | -30 | -25 | -10 | 21 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 63.59% | 63.59% | 63.59% | 63.59% | 63.59% | 59.06% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% |
| FIIs | 0% | 0% | 0% | 0% | 0.02% | 0.01% | 0.05% | 0% | 0.01% | 0.09% | 0.17% | 0% |
| DIIs | 2.46% | 3.86% | 3.86% | 3.86% | 3.86% | 3.86% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% | 10.38% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.89% | 25.21% | 25.55% | 25.57% | 28.55% | 32.34% | 31.86% | 32.01% | 31.7% | 31.84% | 31.56% | 30.73% |
| Others | 7.06% | 7.34% | 7% | 6.98% | 3.99% | 4.74% | 5.08% | 4.99% | 5.3% | 5.07% | 5.28% | 6.27% |
| No. of Shareholders | 10686 | 10028 | 11432 | 11543 | 11282 | 10521 | 10537 | 10317 | 10078 | 10532 | 10741 | 11161 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 7 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 65.19 | Buy |
| EMA (10) | 64.68 | Buy |
| SMA (20) | 63.62 | Buy |
| EMA (20) | 64.25 | Buy |
| SMA (50) | 64.62 | Buy |
| EMA (50) | 64.21 | Buy |
| SMA (100) | 63.23 | Buy |
| EMA (100) | 65.6 | Buy |
| SMA (200) | 68.23 | Sell |
| EMA (200) | 74.62 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.86 | Neutral |
| MACD (12,26,9) | 0.44 | Buy |
| Stochastic (14,3,3) | 37.56 | Neutral |
| ADX (14) | 22.31 | Neutral |
| Williams %R (14) | -52.68 | Neutral |
| ATR (14) | 3.57 | High Volatility |
| ROC (12) | 4.52 | Buy |
| Stoch RSI (14) | 34.35 | Neutral |
| UO (7,14,28) | 39.18 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-04 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccab9e29-7b5d-4c49-a2df-b44560ac2a86.pdf) |
| 2026-09-03 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b59e71d-e7b4-477b-86b8-c45742cf0314.pdf) |
| 2026-08-22 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2aaf5e7d-7928-4e38-b438-a493a81154b6.pdf) |
| 2026-08-21 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a97ec8b6-00b9-4b0d-9210-f46bdd597cd4.pdf) |
| 2026-08-21 | [Addendum To The Notice Of 24Th Annual General Meeting Of The Company.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36a04b6a-2e70-47fd-85da-8d5c4a49dab3.pdf) |
| 2026-08-17 | [Intimation Of Record Date E-Voting Dates And Book Closure Date](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b602dde7-c96b-4a9f-81d5-7f3d658d2dae.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fbf34bb-3016-463a-bef6-ef7797c35827.pdf) |
| 2026-08-13 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=287d492c-be29-4244-9e06-de6e3ec6ebc4.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 13Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87f68bc2-7492-437b-9937-9bfa066c8b79.pdf) |
| 2026-08-12 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4b57cd3b-c7a9-4fb0-b00a-168fae1bdfeb.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Results - Financial Results For June 30 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73676f10-d2c8-4d05-aaa2-1b8d4a31978d.pdf) |
| 2026-05-29 | [Results-Financial Results For March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b651a978-8622-4986-bf81-505d5037b362.pdf) |
| 2026-02-06 | [Financial Results For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49205f08-17bf-4147-a308-126097e1db1b.pdf) |
| 2025-11-14 | [Results For Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa61a187-e56c-4ed9-a161-74b6398c256a.pdf) |
| 2025-08-13 | [Results - Financial Results For June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e65b62ac-d915-4e53-be43-0dd32ef6c7c3.pdf) |
| 2025-05-28 | [Outcome Of Board Meeting Held On Wednesday 28Th May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f38c7151-e9ed-4c09-809d-b7529841fbe0.pdf) |
| 2025-02-13 | [Unaudited Financial Results Both Standalone And Consolidated For The Quarter And Nine Months Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1c46739-65b4-44dc-930c-7a58f7e60c14.pdf) |
| 2024-11-09 | [Unaudited Financial Results, Both Standalone And Consolidated, For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f33089a0-dcfe-481b-9cc8-0bf270363de4.pdf) |
| 2024-08-14 | [Financial Results For Quarter Ended June 30,2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4becc468-a9e4-4a3b-a179-5a4b221fea70.pdf) |
| 2024-05-18 | [Financial Results For Quarter And Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe9ce618-b20e-424b-9c55-5947019091cc.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 March 2026 - Galaxy Infotech Limited has informed about Copy of Newspaper Publication regarding Corrigendum to the Notice of Extra Ordinary General Meeting dated: 17th March, 2026 | [Copy of Newspaper Publication 7 March 2026 - Galaxy Infotech Limited has informed about Copy of Newspaper Publication regarding Corrigendum to the Notice of Extra Ordinary General Meeting dated: 17th March, 2026](https://nsearchives.nseindia.com/corporate/VIRTUAL_07032026160057_intimation-_newspaper_publication-07032026-A4.pdf) |
| 7 Feb - Newspaper Publication dated 7th February 2026 of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Feb - Newspaper Publication dated 7th February 2026 of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7dd271e-2d95-479f-8889-2c1f3ca7d175.pdf) |
| 6 Mar - BSL received exchange no-objection letter valid six months; board to review before NCLT filing (March 6, 2026). | [Update On Scheme Of Arrangement Involving Brooks Steriscience Limited ('BSL'), A Joint Venture / Associate Of The Company. 6 Mar - BSL received exchange no-objection letter valid six months; board to review before NCLT filing (March 6, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/43085688-5c41-44dc-9a17-8caef8dbe209.pdf) |
| 6 Feb - Board approved Q3 & 9M FY26 results to 31-Dec-2025: consolidated PAT Rs2,306.05 lakh; revenue Rs6,552.89 lakh. | [Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 6Th February 2026. 6 Feb - Board approved Q3 & 9M FY26 results to 31-Dec-2025: consolidated PAT Rs2,306.05 lakh; revenue Rs6,552.89 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/95c0f090-6837-4a9c-914a-86460fc68d82.pdf) |
| 5 March 2026 - Corrigendum clarifies preferential issue: VWAP-based minimum price ₹159, 12,43,432 warrants, EGM 17 Mar 2026. | [Corrigendum 5 March 2026 - Corrigendum clarifies preferential issue: VWAP-based minimum price ₹159, 12,43,432 warrants, EGM 17 Mar 2026.](https://nsearchives.nseindia.com/corporate/VIRTUAL_05032026192443_Intimation_under_Reg_30.pdf) |
| 30 Jan - ITAT Chandigarh dismissed Brooks' appeals for AYs 2012-13, 2014-15, 2016-17; company cites no material financial impact. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulation, 2015- ITAT Orders. 30 Jan - ITAT Chandigarh dismissed Brooks' appeals for AYs 2012-13, 2014-15, 2016-17; company cites no material financial impact.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/82ffc902-a27f-41c3-81ae-c41845866450.pdf) |
| 29 Apr - Brooks Laboratories confirms it is not a large corporate for FY2026; outstanding borrowing was Rs 1.19 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Brooks Laboratories confirms it is not a large corporate for FY2026; outstanding borrowing was Rs 1.19 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b1c97e0e-452a-4412-8ebd-dcbe1eddaf7f.pdf) |
| 29 Apr - Brooks Laboratories confirms it is not a large corporate for FY2026; outstanding borrowing was Rs 1.19 crore. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Brooks Laboratories confirms it is not a large corporate for FY2026; outstanding borrowing was Rs 1.19 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b1c97e0e-452a-4412-8ebd-dcbe1eddaf7f.pdf) |
| 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026. | [Closure of Trading Window 25 Mar - Trading window closed from 1 April 2026 until 48 hours after audited results for quarter/year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a74ee4b2-5a50-40bf-98fd-1c9c61c0e56b.pdf) |
| 24 February 2026 - Virtual Galaxy Infotech to hold EGM 17 Mar 2026 10:30 IST via VC; notice published 24 Feb. | [Copy of Newspaper Publication 24 February 2026 - Virtual Galaxy Infotech to hold EGM 17 Mar 2026 10:30 IST via VC; notice published 24 Feb.](https://nsearchives.nseindia.com/corporate/VIRTUAL_24022026144307_Intimation_of_Newspaper_advertisement.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26809_VGINFOTECH_2024_2025_A_09072025165656.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4b57cd3b-c7a9-4fb0-b00a-168fae1bdfeb.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3b3acb6-5fa9-477e-a698-3464d8a520f7.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/27729192-5af3-4d53-9200-8809cbb5f1e8.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8ea2d84f-948d-4ba0-a3ee-584946e279ec.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533543/76318533543.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533543/71725533543.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/533543/65851533543.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/533543/5335430319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/533543/5335430318.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Dec 2025 | [Concall - Dec 2025](https://nsearchives.nseindia.com/corporate/VIRTUAL_01122025163148_Submission_of_Transcript_of_Investor-Analysts_Call_dated-28-11-2025.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:48:15.701Z.